Page last updated: 2024-08-23

zidovudine and Osteoporosis

zidovudine has been researched along with Osteoporosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chin, BS; Kim, HS; Shin, HS	1
Brinkman, K; Danner, SA; Geerlings, SE; Hassink, EA; Lips, P; Reiss, P; Ristola, M; Sutinen, J; van Agtmael, MA; van Vonderen, MG	1
Bernstein, BM; Brown, TT; da Silva, BA; King, MS; McComsey, GA; Qaqish, RB	1

Trials

2 trial(s) available for zidovudine and Osteoporosis

Article	Year
First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir. AIDS (London, England), 2009, Jul-17, Volume: 23, Issue:11 Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Density; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Osteoporosis; Pyrimidinones; Ritonavir; Young Adult; Zidovudine	2009
Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen. Journal of acquired immune deficiency syndromes (1999), 2009, Aug-15, Volume: 51, Issue:5 Topics: Absorptiometry, Photon; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Bone Density; Cyclopropanes; Female; HIV Infections; Humans; Inflammation Mediators; Lamivudine; Lopinavir; Male; Middle Aged; Osteoporosis; Prospective Studies; Pyrimidinones; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Risk Factors; Ritonavir; Zidovudine	2009

Article

Year

First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir.

AIDS (London, England), 2009, Jul-17, Volume: 23, Issue:11

Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Density; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Osteoporosis; Pyrimidinones; Ritonavir; Young Adult; Zidovudine

2009

Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.

Journal of acquired immune deficiency syndromes (1999), 2009, Aug-15, Volume: 51, Issue:5

Topics: Absorptiometry, Photon; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Bone Density; Cyclopropanes; Female; HIV Infections; Humans; Inflammation Mediators; Lamivudine; Lopinavir; Male; Middle Aged; Osteoporosis; Prospective Studies; Pyrimidinones; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Risk Factors; Ritonavir; Zidovudine

2009

Other Studies

1 other study(ies) available for zidovudine and Osteoporosis

Article	Year
Prevalence and risk factors of low bone mineral density in Korean HIV-infected patients: impact of abacavir and zidovudine. Journal of Korean medical science, 2013, Volume: 28, Issue:6 Topics: Adult; Anti-HIV Agents; Asian People; Body Mass Index; Bone Density; Bone Diseases, Metabolic; Dideoxynucleosides; Female; HIV Infections; Humans; Male; Middle Aged; Odds Ratio; Osteoporosis; Prevalence; Republic of Korea; Retrospective Studies; Risk Factors; Zidovudine	2013

Article

Year

Prevalence and risk factors of low bone mineral density in Korean HIV-infected patients: impact of abacavir and zidovudine.

Journal of Korean medical science, 2013, Volume: 28, Issue:6

Topics: Adult; Anti-HIV Agents; Asian People; Body Mass Index; Bone Density; Bone Diseases, Metabolic; Dideoxynucleosides; Female; HIV Infections; Humans; Male; Middle Aged; Odds Ratio; Osteoporosis; Prevalence; Republic of Korea; Retrospective Studies; Risk Factors; Zidovudine

2013